Showing results (471-480 of 739) with videos related to
Sort By:
Pageof 74
JCO Oncology Practice|April 3, 2025
Predictors of Cardiac Recovery in Adults With AML Who Develop Heart Failure During TreatmentMatthew Wu, Kathryn Russell, Carole M Shaw, et al.Journal of Neural Engineering|December 5, 2017
Signal processing methods for reducing artifacts in microelectrode brain recordings caused by functional electrical stimulationD Young, F Willett, W D Memberg, et al.Biology of Reproduction|March 11, 2005
Nucleotide excision repair activity varies among murine spermatogenic cell typesGuogang Xu, Graciela Spivak, David L Mitchell, et al.Plos One|August 26, 2015
The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and RiskKimberly H Harrington, Chelsea J Gudgeon, George S Laszlo, et al.Bone Marrow Transplantation|December 28, 2022
Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or second remissionRoland B Walter, Brenda M Sandmaier, Megan Othus, et al.Frontiers in Physiology|March 16, 2023
Functional characterization of maternally accumulated hydrolases in the mature oocytes of the vector Rhodnius prolixus reveals a new protein phosphatase essential for the activation of the yolk mobilization and embryo developmentElisa de Almeida, Uilla Dittz, Jéssica Pereira, et al.Bone Marrow Transplantation|January 29, 2025
Relationship between age, conditioning intensity, and outcome after allografting in adults age ≥60 years with AMLPhuong T Vo, Brenda M Sandmaier, Megan Othus, et al.Blood Advances|October 7, 2024
Measurable residual disease as predictor of post-day +100 relapses after allografting in adult AMLNaveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, et al.Leukemia|March 24, 2021
Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerationsRoland B Walter, Yishai Ofran, Agnieszka Wierzbowska, et al.Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|June 14, 2011
Identification of robust hypoxia biomarker candidates from fin of medaka (Oryzias latipes)Ziping Zhang, Melissa C Wells, Mikki G Boswell, et al.Pageof 74